Self-Collection for Cervical Cancer Screening in a Safety‑Net Setting
During 2008‑2022, cervical precancer incidence decreased 79% and higher‑grade precancer incidence decreased 80% among screened women aged 20‑24 years, the age group most likely to have been vaccinated.
Evidence level: Megerősített klinikai bizonyíték. Több vagy erősebb humán vizsgálat támogatja.
Related signals
- A multinational cross-sectional study on human papillomavirus and cervical cancer knowledge, vaccination attitudes, and risk factors in the Middle East
- Genomic features of cervical cancer
- Screening for Cervical Cancer
- Cervical cancer: Epidemiology, risk factors and screening
- AI approach outperformed human experts in identifying cervical precancer